Cargando…
Enhanced Antitumor Effect of 5′‐Deoxy‐5‐fluorouridine by Oral Administration with l‐Cysteine
When given orally in combination with l‐cysteine, 5′‐deoxy‐5‐fluorouridine (DFUR) brought about a significant reduction in the growth of adenocarcinoma 755 and a significant prolongation of life‐span in mice bearing Lewis lung carcinoma without increased toxicity to the host as compared with DFUR al...
Autores principales: | Iigo, Masaaki, Nakajima, Yoko, Araki, Eiji, Hoshi, Akio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Blackwell Publishing Ltd
1989
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5917697/ https://www.ncbi.nlm.nih.gov/pubmed/2524459 http://dx.doi.org/10.1111/j.1349-7006.1989.tb02287.x |
Ejemplares similares
-
Optimal Treatment Regimens for 5′‐Deoxy‐5‐fluorouridine, with or without (E)‐5‐(2‐Bromovinyl)‐2′‐deoxyuridine, against Various Tumors in Mice
por: Iigo, Masaaki, et al.
Publicado: (1990) -
Comparative Antitumor Activity and Intestinal Toxicity of 5′‐Deoxy‐5‐fluorouridine and Its Prodrug Trimethoxybenzoyl‐5′‐deoxy‐5‐fluorocytidine
por: Ninomiya, Yasuyuki, et al.
Publicado: (1990) -
Antitumor Effects of 5′‐Deoxy‐S‐fluorouridine in Combination with Recombinant Human Interleukin 2 on Murine Colon Carcinoma 26
por: Midoro, Katsuo, et al.
Publicado: (1997) -
Comparative Antitumor Activity of 5‐Fluorouracil and 5′‐Deoxy‐5‐fluorouridine in Combination with Radiation Therapy in Mice Bearing Colon 26 Adcnocarcinoma
por: Ishikawa, Tohru, et al.
Publicado: (1989) -
The potential for oral combination chemotherapy of 5′-deoxy-5-fluorouridine, a 5-FU prodrug, and cyclophosphamide for metastatic breast cancer
por: Yoshimoto, M, et al.
Publicado: (2003)